ANI Pharmaceuticals To Present At Upcoming November Investor Conferences
| Event | Guggenheim 3rd Annual Healthcare Innovation Conference |
| Date | Tuesday, November 10, 2026 |
| Time | 1:30 p.m. ET |
| Webcast | Click here |
| Event | 2026 Jefferies Global Healthcare Conference in London |
| Date | Tuesday, November 17, 2026 |
| Time | 9:30 a.m. GMT |
| Webcast | Click here |
The live and archived webcasts will also be accessible from the Company's website at , in the Investors section under Events and Presentations.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of“Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E:...
Media Relations:
Argot Partners
T: 212-600-1494
E:...
SOURCE: ANI Pharmaceuticals, Inc.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment